Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511].

Autor: Liu X; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Munro AP; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Feng S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Janani L; Imperial Clinical Trials Unit, Imperial College London, London, UK., Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Babbage G; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Baxter D; Stockport NHS Foundation Trust, Stockport, UK., Bula M; NIHR Liverpool and Broadgreen Clinical Research Facility, Liverpool, UK., Cathie K; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Chatterjee K; NIHR Cambridge Clinical Research Facility, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Dejnirattisai W; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Dodd K; NIHR Liverpool and Broadgreen Clinical Research Facility, Liverpool, UK., Enever Y; PHARMExcel, Welwyn Garden City, Hertfordshire, UK., Qureshi E; NIHR/Wellcome Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Goodman AL; Department of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK; MRC Clinical Trials Unit, University College London, London, UK., Green CA; NIHR/Wellcome Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Harndahl L; Portsmouth Hospitals University NHS Trust, Portsmouth, UK., Haughney J; Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, Glasgow, UK., Hicks A; Portsmouth Hospitals University NHS Trust, Portsmouth, UK., van der Klaauw AA; Wellcome-MRC Institute of Metabolic Science, Department of Clinical Biochemistry, University of Cambridge, Cambridge, UK., Kwok J; Cancer Research UK Oxford Centre, University of Oxford, Oxford, UK., Libri V; NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK., Llewelyn MJ; University Hospitals Sussex NHS Foundation Trust, Brighton, UK., McGregor AC; Department of Infectious Diseases and Tropical Medicine, London Northwest University Healthcare, London, UK., Minassian AM; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Moore P; The Adam Practice, Poole, UK., Mughal M; Stockport NHS Foundation Trust, Stockport, UK., Mujadidi YF; NIHR Oxford Biomedical Research Centre, Oxford, UK., Holliday K; NIHR Leeds Clinical Research Facility, Leeds Teaching Hospitals Trust and University of Leeds, Leeds, UK., Osanlou O; Public Health Wales, Betsi Cadwaladr University Health Board, Bangor University, Bangor, UK., Osanlou R; University of Liverpool, Liverpool, UK., Owens DR; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Pacurar M; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Palfreeman A; University Hospitals of Leicester NHS Trust, University of Leicester, Leicester, UK., Pan D; University Hospitals of Leicester NHS Trust, University of Leicester, Leicester, UK., Rampling T; NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK., Regan K; Bradford Institute for Health Research and Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK., Saich S; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Serafimova T; Department of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK., Saralaya D; Bradford Institute for Health Research and Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK., Screaton GR; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Sharma S; University Hospitals Sussex NHS Foundation Trust, Brighton, UK., Sheridan R; Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter, UK., Sturdy A; Department of Infectious Diseases and Tropical Medicine, London Northwest University Healthcare, London, UK., Supasa P; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Thomson EC; Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, Glasgow, UK; MRC University of Glasgow Centre for Virus Research, Glasgow, UK., Todd S; Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter, UK., Twelves C; NIHR Leeds Clinical Research Facility, Leeds Teaching Hospitals Trust and University of Leeds, Leeds, UK., Read RC; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK., Charlton S; UK Health Security Agency, Porton Down, UK., Hallis B; UK Health Security Agency, Porton Down, UK., Ramsay M; UK Health Security Agency, Colindale, London, UK., Andrews N; UK Health Security Agency, Colindale, London, UK., Lambe T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Nguyen-Van-Tam JS; Division of Epidemiology and Public Health, University of Nottingham School of Medicine, UK., Cornelius V; Imperial Clinical Trials Unit, Imperial College London, London, UK., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK., Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK. Electronic address: s.faust@soton.ac.uk.

Publikováno v: The Journal of infection [J Infect] 2023 May; Vol. 86 (5), pp. 540-541. Date of Electronic Publication: 2023 Apr 12.

Influenza A virus continues to circulate among children in Linyi, northern China, after the relaxation of COVID-19 control measures.

Autor: Lv, Tiegang^1,2 (AUTHOR), Chen, Jie² (AUTHOR), Li, Huafeng² (AUTHOR), Chen, Xiaoyan² (AUTHOR), Zhang, Na¹ (AUTHOR), Ma, Chunling² (AUTHOR), Zhang, Yanli² (AUTHOR), You, Pengfei¹ (AUTHOR) 13562993937@163.com

Publikováno v: Scientific Reports. 12/4/2024, Vol. 14 Issue 1, p1-12. 12p.

Factors Associated With the Declining Trends of Hip Fractures.

Autor: Fuller-Thomson E; University of Toronto, Toronto, Ontario, Canada., Munro AP; University of Toronto, Toronto, Ontario, Canada.

Publikováno v: JAMA internal medicine [JAMA Intern Med] 2021 Feb 01; Vol. 181 (2), pp. 294-295.

Importance of considering the role of tetraethyl lead when examining the relationship between environmental pollution and psychotic disorders.

Autor: Fuller-Thomson E; University of Toronto, 246 Bloor St. W., Toronto, ON M5S 1V4, Canada. Electronic address: esme.fuller.thomson@utoronto.ca., Munro AP; University of Toronto, 246 Bloor St. W., Toronto, ON M5S 1V4, Canada.

Publikováno v: Schizophrenia research [Schizophr Res] 2018 May; Vol. 195, pp. 570-571. Date of Electronic Publication: 2017 Oct 16.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.